Gilead Sciences, Inc. (GILD)
148.86
+0.77
(+0.52%)
USD |
NASDAQ |
Aug 27, 16:00
148.86
0.00 (0.00%)
After-Hours: 16:32
Gilead Sciences EPS Diluted (TTM) : -2.656 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.656 |
| March 31, 2026 | 7.349 |
| December 31, 2025 | 6.782 |
| September 30, 2025 | 6.456 |
| June 30, 2025 | 5.027 |
| March 31, 2025 | 4.756 |
| December 31, 2024 | 0.3672 |
| September 30, 2024 | 0.0887 |
| June 30, 2024 | 0.8182 |
| March 31, 2024 | 0.3587 |
| December 31, 2023 | 4.504 |
| September 30, 2023 | 4.664 |
| June 30, 2023 | 4.348 |
| March 31, 2023 | 4.425 |
| December 31, 2022 | 3.639 |
| September 30, 2022 | 2.644 |
| June 30, 2022 | 3.280 |
| March 31, 2022 | 3.580 |
| December 31, 2021 | 4.934 |
| September 30, 2021 | 5.864 |
| June 30, 2021 | 4.095 |
| March 31, 2021 | 0.2268 |
| December 31, 2020 | 0.0781 |
| September 30, 2020 | 0.964 |
| June 30, 2020 | -0.241 |
| Date | Value |
|---|---|
| March 31, 2020 | 3.892 |
| December 31, 2019 | 4.210 |
| September 30, 2019 | 2.094 |
| June 30, 2019 | 4.618 |
| March 31, 2019 | 4.536 |
| December 31, 2018 | 4.167 |
| September 30, 2018 | 1.207 |
| June 30, 2018 | 1.663 |
| March 31, 2018 | 2.607 |
| December 31, 2017 | 3.484 |
| September 30, 2017 | 8.783 |
| June 30, 2017 | 9.209 |
| March 31, 2017 | 9.457 |
| December 31, 2016 | 9.935 |
| September 30, 2016 | 10.77 |
| June 30, 2016 | 11.35 |
| March 31, 2016 | 11.68 |
| December 31, 2015 | 11.92 |
| September 30, 2015 | 10.92 |
| June 30, 2015 | 9.531 |
| March 31, 2015 | 8.810 |
| December 31, 2014 | 7.375 |
| September 30, 2014 | 5.658 |
| June 30, 2014 | 4.455 |
| March 31, 2014 | 2.715 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 17.19 |
| AbbVie, Inc. | 3.537 |
| Regeneron Pharmaceuticals, Inc. | 40.46 |
| Amgen, Inc. | 16.10 |
| Biogen, Inc. | 5.647 |